William A. Hawkins - May 24, 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: Director
Signature: /s/Anthony D'Adamio, Attorney-in-Fact
Stock symbol: BVS
Transactions as of: May 24, 2023
Transactions value $: $235,567
Form type: 4
Date filed: 5/26/2023, 04:28 PM
Previous filing: Jun 22, 2022
Next filing: Jun 8, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Purchase	$118K	+44K	+45.69%	$2.69	140K	May 24, 2023	Direct	F1
transaction	BVS	Class A Common Stock	Purchase	$117K	+44K	+31.36%	$2.66	184K	May 25, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.61 to $2.78, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.57 to $2.71, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.61 to $2.78, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.57 to $2.71, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.